Melanocortins and agouti-related protein modulate the excitability of two arcuate nucleus neuron populations by alteration of resting potassium conductances

Journal of Physiology

Volumn 578, Issue 2, 2007, Pages 425-438

  Smith, Mark A ^a   Hisadome, Kazunari ^a   Al qassab, Hind ^b   Heffron, Helen ^b   Withers, Dominic J ^b   Ashford, Michael L J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; CRE RECOMBINASE; INSULIN; MELANOCORTIN; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; PEPTIDE; PROOPIOMELANOCORTIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; MELANOCORTIN RECEPTOR AGONIST; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; CELL POPULATION; CONTROLLED STUDY; DEPOLARIZATION; ENERGY BALANCE; FOOD INTAKE; GENE EXPRESSION; HYPERPOLARIZATION; HYPOTHALAMUS; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE; VOLTAGE CLAMP; ACTION POTENTIAL AMPLITUDE; EXCITATORY POSTSYNAPTIC POTENTIAL; HOMEOSTASIS; INACTIVATION TIME CONSTANT; INHIBITORY POSTSYNAPTIC POTENTIAL; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROMODULATION; PROTEIN FUNCTION; TRANSPORT KINETICS;

4-AMINOPYRIDINE; ACTION POTENTIALS; ADENYLATE CYCLASE; ALPHA-MSH; ANIMALS; ARCUATE NUCLEUS; BARIUM; GREEN FLUORESCENT PROTEINS; INTEGRASES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANOCORTINS; MELANOCYTE-STIMULATING HORMONES; MICE; MICE, TRANSGENIC; NEURONS; PATCH-CLAMP TECHNIQUES; PEPTIDES, CYCLIC; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4; SYNAPTIC TRANSMISSION;

EID: 33846191084     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.119479     Document Type: Article

References (42)

1. Acuna-Goycolea C & van den Pol AN (2005). Peptide YY3-36 inhibits both anorexiogenic proopiomelanocortin and orexigenic neuropeptide Y neurons: Implications for hypothalamic regulation of energy homeostasis. J Neurosci 25, 10510-10519.
2. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T et al. (2005). Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123, 493-505.
3. Bays HE (2004). Current and investigational anti-obesity agents and obesity therapeutic treatment targets. Obes Res 12, 1197-1211.
4. Bednarek MA, MacNeil T, Tang R, Kalyani RN, van der Ploeg LH & Weinberg DH (2001). Potent and selective peptide agonists of α-melanotropin action at human melanocortin receptor 4: Their synthesis and biological evaluation in vitro. Biochem Biophys Res Commun 286, 641-645.
5. Bonilla C, Panguluri RK, Taliaferro-Smith L, Argyropoulos G, Chen G, Adeyemo AA et al. (2006). Agouti-related protein promoter variant associated with leanness and decreased risk for diabetes in West Africans. Int J Obes 30, 715-721.
6. Burdakov D & Ashcroft FM (2002). Cholecystokinin tunes firing of an electrically distinct subset of arcuate nucleus neurons by activating A-type potassium channels. J Neurosci 22, 6380-6387.
7. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M & Cone RD (2000). A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141, 3518-3521.
8. Choudhury AI, Heffron H, Smith MA, Al-Qassab H, Xu AW, Selman C et al. (2005). The role of insulin receptor substrate 2 in hypothalamic and β cell function. J Clin Invest 115, 940-950.
9. Cone RD (2005). Anatomy and regulation of the central melanocortin system. Nat Neurosci 8, 571-578.
10. Cowley MA (2003). Hypothalamic melanocortin neurons integrate signals of energy state. Eur J Pharmacol 480, 3-11.
11. Cowley MA, Smart JL, Rubinstein M, Cerdán MG, Diano S, Horvath TL, Cone RD & Low MJ (2001). Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480-484.
12. Dhillon H, Zigman JM, Ye C, Lee CE, McGovern RA, Tang V et al. (2006). Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 49, 191-203.
13. Erickson JC, Clegg KE & Palmiter RD (1996). Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381, 415-418.
14. Fan W, Boston BA, Kesterson RA, Hruby VJ & Cone RD (1997). Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165-168.
15. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T & O'Rahilly S (2000). Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 106, 271-279.
16. Fekete C, Marks DL, Sarkar S, Emerson CH, Rand WM, Cone RD & Lechan RM (2004). Effect of agouti-related protein in regulation of the hypothalamic-pituitary-thyroid axis in the melanocortin 4 receptor knockout mouse. Endocrinology 145, 4816-4821.
17. Graham M, Shutter JR, Sarmiento U, Sarosi I & Stark KL (1997). Over-expression of Agrt leads to obesity in transgenic mice. Nat Genet 17, 273-274.
18. Gropp E, Shanabrough M, Borok E, Xu AW, Janoschek R, Buch T et al. (2005). Agouti-related peptide-expressing neurons are mandatory for feeding. Nat Neurosci 8, 1289-1291.
19. Hagan MM, Rushing PA, Pritchard LM, Schwartz MW, Strack AM, Van der Ploeg LH, Woods SC & Seeley RJ (2000). Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin blockade. Am J Physiol Regul Integr Comp Physiol 279, R47-R52.
20. Harrold JA, Widdowson PS & Williams G (1999). Altered energy balance causes selective changes in melanocortin-4 (MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding. Diabetes 48, 267-271.
21. Haskell-Luevano C & Monck EK (2001). Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul Pept 99, 1-7.
22. Hille B (2001). Ion Channels of Excitable Membrane, 3rd edn. Sinauer Associates Inc., Massachusetts, USA.
23. Huszar D, Lynch C, Rair-Huntress V, Dunmore JH, Fang Q, Berkemeier LR et al. (1997). Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131-141.
24. Ibrahim N, Bosch MA, Smart JL, Qiu J, Rubinstein M, Rønnekleiv OK, Low MJ & Kelly MJ (2003). Hypothalamic proopiomelanocortin neurons are glucose responsive and express K ATP channels. Endocrinology 144, 1331-1340.
25. + channels in a use-dependent manner. J Pharmacol Exp Ther 314, 1353-1361.
26. Kas MJ, van Dijk G, Scheurink AJ & Adan RA (2003). Agouti-related protein prevents self-starvation. Mol Psychiatry 8, 235-240.
27. Kim MS, Rossi M, Abbott CRAI, Ahmed SH, Smith DM & Bloom SR (2002). Sustained orexigenic effect of Agouti related protein may not be mediated by the melanocortin receptor. Peptides 23, 1069-1076.
28. Kim MS, Rossi M, Abusnana S, Sunter D, Morgan DG, Small CJ et al. (2000). Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes 49, 177-182.
29. Lechan RM & Tatro JB (2001). Hypothalamic melanocortin signaling in cachexia. Endocrinology 142, 3288-3291.
30. + channels from guinea-pig cardiomyocytes. J Physiol 532, 115-126.
31. Liu H, Kishi T, Roseberry AG, Cai X, Lee CE, Montez JM, Friedman JM & Elmquist JK (2003). Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J Neurosci 23, 7143-7154.
32. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB & Cone RD (1994). Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8, 1298-1308.
33. Nijenhuis WA, Oosterom J & Adan RA (2001). AgRP (83-132) acts as an inverse agonist on the human melanocortin-4 receptor. Mol Endocrinol 15, 164-171.
34. Plum L, Ma X, Hampel B, Balthasar N, Coppari R, Münzberg H et al. (2006). Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity. J Clin Invest 116, 1886-1901.
35. Ramos EJ, Meguid MM, Campos AC & Coelho JC (2005). Neuropeptide Y, α-melanocyte-stimulating hormone, and monoamines in food intake regulation. Nutrition 21, 269-279.
36. Roseberry AG, Liu H, Jackson AC, Cai X & Friedman JM (2004). Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 41, 711-722.
37. Srinivasan S, Lubrano-Berthelier C, Govaerts C, Picard F, Santiago P, Conklin BR & Vaisse C (2004). Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J Clin Invest 114, 1158-1164.
38. + current of mouse pancreatic beta-cells. Pflugers Arch 431, 625-631.
39. + current in neurons of the mammalian hypothalamus. J Neurophysiol 94, 2983-2986.
40. + currents in identified olfactory bulb output neurones of rats. J Physiol 490, 63-77.
41. Wikberg JE (1999). Melanocortin receptors: Perspectives for novel drugs. Eur J Pharmacol 375, 295-310.
42. Yang YK, Thompson DA, Dickinson CJ, Wilken J, Barsh GS, Kent SB & Gantz I (1999). Characterization of agouti-related protein binding to melanocortin receptors. Mol Endocrinol 13, 148-155.